The Trump administration finalized on Monday that payment rate increases for private Medicare plans in 2027 will be significantly higher than initially proposed, a move that boosted the stock prices of health insurance companies.
According to an announcement from the Centers for Medicare & Medicaid Services (CMS), the government will raise the average payment for Medicare Advantage plans by 2.48% in 2027, representing an increase of more than $13 billion. This contrasts sharply with the administration's proposal in January of this year, which suggested a mere 0.09% increase—a proposal that had severely impacted the stock prices of insurers operating these plans.
In after-hours trading on Monday, shares of UnitedHealth Group and CVS Health both rose more than 9%, while Humana's stock surged approximately 12%.
Dr. Mohammed OZ, CMS Administrator, stated in the announcement, "Medicare Advantage and Part D prescription drug plans should serve the people who rely on them. These adjustments help maintain the affordability of coverage and ensure patients receive meaningful value from their chosen plans."
This closely watched government payment rate determines the level of monthly premiums insurers can set, the benefits plans can offer, and ultimately impacts their profitability.
Medicare Advantage plans are private health insurance plans authorized by Medicare. Data from the health policy research organization KFF indicates that more than half of all Medicare beneficiaries are now enrolled in such plans, attracted by lower monthly premiums and additional benefits not covered by traditional Medicare.
Comments